Renal Cancers Completed Phase 1 Trials for Panitumumab (DB01269)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00004879Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction CancerTreatment